Figure 3From: Inhibition of AMPK expression in skeletal muscle by systemic inflammation in COPD ratsMorphological changes of the skeletal muscle in control rats and COPD model rats that were treated with vehicles, AICAR or resveratrol at week 20 (H & E stained). (A) Control rats; (B) COPD rats with vehicle; (C) COPD rats with AICAR treatment; and (D) COPD rats with resveratrol treatment. Amplification ×200.Back to article page